← Back to Search

EMMA App + Clinician Support for Cognitive Impairment (EMMA Trial)

N/A

Recruiting

Led By Maureen Schmitter-Edgecombe, PhD

Research Sponsored by Washington State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at baseline and 6 month follow-up

Awards & highlights

No Placebo-Only Group

Summary

This trial studies an app-based system to help older adults with memory & daily activity management. It asks if clinician oversight is needed for use of the app.

Who is the study for?

This trial is for older adults aged 50 or above who feel they have memory issues but can still read and speak English. It's not suitable for those with severe vision or hearing problems, unable to consent, or have a medical condition like stroke explaining their cognitive complaints.

What is being tested?

The study tests a web-based training program teaching the use of an app called EMMA, designed to help with memory and daily tasks. The role of clinician support in learning to use this app effectively will also be assessed.

What are the potential side effects?

Since this intervention involves using an application and web-based training, side effects are minimal but may include discomfort from prolonged screen time or frustration if difficulties arise while learning the technology.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at baseline and 6 month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at baseline and 6 month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline and 6 month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Cognitive Self-efficacy Questionnaire (CSEQ)

Change in Daily Assessment of Independent Living and Executive Skills (DAILIES)

Change in EMMA app use daily interactions

+1 more

Secondary study objectives

Change in Coping Self-efficacy Scale (CSES)

Change in Everyday Compensation questionnaire (Ecomp)

Change in Patient-Reported Outcome Measurement Information (PROMIS) System Applied Cognition

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Brief Clinician Motivational SupportExperimental Treatment2 Interventions

Participants will learn to use the EMMA app through a personalized web-based training platform with brief weekly motivational support from a clinician.

Group II: Technology Support OnlyActive Control1 Intervention

Participants will learn to use the EMMA app through a personalized web-based training platform with technical support and reminders as needed.

Do I qualify?Apply below to find out